![](/img/cover-not-exists.png)
It is time to consider third-line options in antiretroviral-experienced paediatric patients?
Gert U van Zyl, Helena Rabie, James J Nuttall, Mark F CottonVolume:
14
Language:
english
DOI:
10.1186/1758-2652-14-55
Date:
December, 2011
File:
PDF, 167 KB
english, 2011